1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Influenza Diagnostics Market
2.3. Global Influenza Diagnostics Market, By Test, 2025 (US$ Million)
2.4. Global Influenza Diagnostics Market, By Geography, 2025 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2025
3. Influenza Diagnostics Market: Competitive Analysis
3.1. Market Positioning of Key Influenza Diagnostics Market Vendors
3.2. Strategies Adopted by Influenza Diagnostics Market Vendors
4. Influenza Diagnostics Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Influenza Diagnostics Market Value, 2024 - 2034, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Social Landscape
4.6.4. Technology Landscape
4.6.5. Environmental Landscape
4.6.6. Legal Landscape
5. Influenza Diagnostics Market: By Test, 2024-2034, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2025 Versus 2034
5.3. Market Segmentation
5.3.1. Rapid Influenza Diagnostic Tests (RIDT)
5.3.2. RT-PCR
5.3.3. Cell Culture
5.3.4. Other
6. North America Influenza Diagnostics Market, 2024-2034, USD (Million)
6.1. Market Overview
6.2. Influenza Diagnostics Market: By Test, 2024-2034, USD (Million)
6.3. Influenza Diagnostics Market: By Region, 2024-2034, USD (Million)
6.3.1.North America
6.3.1.1. U.S.
6.3.1.1.1. Influenza Diagnostics Market: By Test, 2024-2034, USD (Million)
6.3.1.2. Canada
6.3.1.2.1. Influenza Diagnostics Market: By Test, 2024-2034, USD (Million)
6.3.1.3. Rest of North America
6.3.1.3.1. Influenza Diagnostics Market: By Test, 2024-2034, USD (Million)
7. UK and European Union Influenza Diagnostics Market, 2024-2034, USD (Million)
7.1. Market Overview
7.2. Influenza Diagnostics Market: By Test, 2024-2034, USD (Million)
7.3. Influenza Diagnostics Market: By Region, 2024-2034, USD (Million)
7.3.1.UK and European Union
7.3.1.1. UK
7.3.1.1.1. Influenza Diagnostics Market: By Test, 2024-2034, USD (Million)
7.3.1.2. Germany
7.3.1.2.1. Influenza Diagnostics Market: By Test, 2024-2034, USD (Million)
7.3.1.3. Spain
7.3.1.3.1. Influenza Diagnostics Market: By Test, 2024-2034, USD (Million)
7.3.1.4. Italy
7.3.1.4.1. Influenza Diagnostics Market: By Test, 2024-2034, USD (Million)
7.3.1.5. France
7.3.1.5.1. Influenza Diagnostics Market: By Test, 2024-2034, USD (Million)
7.3.1.6. Rest of Europe
7.3.1.6.1. Influenza Diagnostics Market: By Test, 2024-2034, USD (Million)
8. Asia Pacific Influenza Diagnostics Market, 2024-2034, USD (Million)
8.1. Market Overview
8.2. Influenza Diagnostics Market: By Test, 2024-2034, USD (Million)
8.3. Influenza Diagnostics Market: By Region, 2024-2034, USD (Million)
8.3.1.Asia Pacific
8.3.1.1. China
8.3.1.1.1. Influenza Diagnostics Market: By Test, 2024-2034, USD (Million)
8.3.1.2. Japan
8.3.1.2.1. Influenza Diagnostics Market: By Test, 2024-2034, USD (Million)
8.3.1.3. India
8.3.1.3.1. Influenza Diagnostics Market: By Test, 2024-2034, USD (Million)
8.3.1.4. Australia
8.3.1.4.1. Influenza Diagnostics Market: By Test, 2024-2034, USD (Million)
8.3.1.5. South Korea
8.3.1.5.1. Influenza Diagnostics Market: By Test, 2024-2034, USD (Million)
8.3.1.6. Rest of Asia Pacific
8.3.1.6.1. Influenza Diagnostics Market: By Test, 2024-2034, USD (Million)
9. Latin America Influenza Diagnostics Market, 2024-2034, USD (Million)
9.1. Market Overview
9.2. Influenza Diagnostics Market: By Test, 2024-2034, USD (Million)
9.3. Influenza Diagnostics Market: By Region, 2024-2034, USD (Million)
9.3.1.Latin America
9.3.1.1. Brazil
9.3.1.1.1. Influenza Diagnostics Market: By Test, 2024-2034, USD (Million)
9.3.1.2. Mexico
9.3.1.2.1. Influenza Diagnostics Market: By Test, 2024-2034, USD (Million)
9.3.1.3. Rest of Latin America
9.3.1.3.1. Influenza Diagnostics Market: By Test, 2024-2034, USD (Million)
10. Middle East and Africa Influenza Diagnostics Market, 2024-2034, USD (Million)
10.1. Market Overview
10.2. Influenza Diagnostics Market: By Test, 2024-2034, USD (Million)
10.3. Influenza Diagnostics Market: By Region, 2024-2034, USD (Million)
10.3.1.Middle East and Africa
10.3.1.1. GCC
10.3.1.1.1. Influenza Diagnostics Market: By Test, 2024-2034, USD (Million)
10.3.1.2. Africa
10.3.1.2.1. Influenza Diagnostics Market: By Test, 2024-2034, USD (Million)
10.3.1.3. Rest of Middle East and Africa
10.3.1.3.1. Influenza Diagnostics Market: By Test, 2024-2034, USD (Million)
11. Company Profile
11.1. Alere (Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
11.2. Becton, Dickinson and Company
11.3. Meridian Bioscience, Inc.
11.4. Princeton BioMedtech corp.
11.5. Quidel Corporation
11.6. Roche Diagnostics
11.7. SA Scientific Inc.
11.8. Sekisui Diagnostics
11.9. Thermo Fisher Scientific
